Antistaphylococcal Activity of Dalbavancin, an Experimental Glycopeptide

Dalbavancin, tested against 146 staphylococci, was more potent than other drugs tested, with an MIC at which 50% of staphylococci were inhibited of 0.03 μg/ml and an MIC at which 90% of staphylococci were inhibited of 0.06 μg/ml by microdilution. For all strains, MICs of vancomycin, linezolid, ranbe...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Lin, Gengrong, Credito, Kim, Ednie, Lois M., Appelbaum, Peter C.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2005
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC547276/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15673763/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.49.2.770-772.2005
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!